Aristotle Capital Boston, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001633911

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q4 2024 · 127 positions · Total reported value $2.70B · Top-10 concentration 22.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 95.2% · 6 new · 106 cut · 7 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.1% · vs SPY -6.2% · Prev Value $1.49B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +6.2% · vs SPY +4.0% · Latest Value $1.13B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Aristotle Capital Boston, LLC disclosed 127 equity positions with a combined reported value of $2.70B. The filing implies a diversified portfolio: its ten largest positions account for 22.0% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q4 2024 were HURN ($72.53M), MTSI ($66.26M), MMSI ($63.72M). By sector, the heaviest allocations are Consumer Discretionary 22.3%, Industrials 14.0%. Versus the prior quarter, allocation shifted toward Materials (+3.1pp), Consumer Discretionary (+1.4pp) and away from Health Care (-0.5pp), Financials (-1.0pp).

Versus the prior quarter, Aristotle Capital Boston, LLC opened 6 new positions, trimmed 106 and fully exited 7, a turnover rate of 95.2% of positions. The portfolio's overlap with the prior quarter was 94% of names.

The largest new positions opened in Q4 2024 were AXTA ($19.00M), HXL ($14.84M), COLD ($13.37M).

Of the 7 positions fully exited versus the prior quarter, the largest were AZPN ($30.03M), INFN ($17.75M), CTLT ($4.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • AXTA AXALTA COATING SYS LTD · $19.00M
  • HXL HEXCEL CORP NEW · $14.84M
  • COLD AMERICOLD REALTY TRUST INC · $13.37M
  • DOC HEALTHPEAK PROPERTIES INC · $3.07M

Fully Exited (vs previous quarter)

  • AZPN ASPEN TECHNOLOGY INC · prev qtr: $30.03M
  • INFN INFINERA CORP · prev qtr: $17.75M
  • CTLT CATALENT INC · prev qtr: $4.03M
  • PETQ PETIQ INC · prev qtr: $1.15M

Insider Transactions (Form 4)

Latest Aristotle Capital Boston, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Aristotle Capital Boston, LLC is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 119 US equity positions with a combined value of $1.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-80368 (status: Approved), registered 2014-10-02
  • Regulatory AUM (Form ADV): $1.83B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 88%, registered investment companies 10%

Portfolio Structure

  • 119 positions · $1.49B reported value (Q2 2026)
  • Top 10 holdings = 19.7% of reported value
  • Largest position: MTSI (MACOM TECH SOLUTIONS HLDGS I) at 2.6%
  • Average position size: $12.53M

Sector Tilt

  • Financials 21.1%
  • Consumer Discretionary 20.1%
  • Industrials 16.6%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 2 new, 6 added, 111 reduced, 5 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Industrials 14.0%
Financials 13.7%
Health Care 11.8%
Technology 9.2%
Energy 3.8%
Materials 3.1%
Other 22.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 583.73K $72.53M 2.69%
2.69%
Reduce
2 510.01K $66.26M 2.45%
2.45%
Reduce
3 658.78K $63.72M 2.36%
2.36%
Reduce
4 663.15K $63.46M 2.35%
2.35%
Reduce
5 560.94K $60.91M 2.26%
2.26%
Reduce
6 1.13M $58.87M 2.18%
2.18%
Reduce
7 318.11K $55.37M 2.05%
2.05%
Reduce
8 573.44K $55.02M 2.04%
2.04%
Add
9 976.74K $49.42M 1.83%
1.83%
Reduce
10 436.50K $49.15M 1.82%
1.82%
Reduce
11 424.50K $49.09M 1.82%
1.82%
Reduce
12 329.37K $46.81M 1.73%
1.73%
Reduce
13 242.15K $46.21M 1.71%
1.71%
Reduce
14 583.47K $45.56M 1.69%
1.69%
Reduce
15 956.12K $45.39M 1.68%
1.68%
Reduce
16 998.25K $42.98M 1.59%
1.59%
Reduce
17 78.39K $41.53M 1.54%
1.54%
Reduce
18 852.20K $40.28M 1.49%
1.49%
Reduce
19 2.01M $40.12M 1.49%
1.49%
Reduce
20 1.08M $38.90M 1.44%
1.44%
Reduce
21 456.99K $38.09M 1.41%
1.41%
Reduce
22 1.20M $37.79M 1.40%
1.40%
Reduce
23 360.88K $37.11M 1.38%
1.38%
Hold
24 1.37M $36.65M 1.36%
1.36%
Hold
25 598.90K $34.69M 1.28%
1.28%
Reduce
26 1.85M $34.17M 1.27%
1.27%
Reduce
27 420.66K $33.64M 1.25%
1.25%
Reduce
28 986.71K $33.37M 1.24%
1.24%
Add
29 1.11M $32.06M 1.19%
1.19%
Reduce
30 1.22M $31.90M 1.18%
1.18%
Reduce
31 456.39K $29.99M 1.11%
1.11%
Reduce
32 573.66K $29.86M 1.11%
1.11%
Reduce
33 380.62K $29.72M 1.10%
1.10%
Add
34 698.70K $29.70M 1.10%
1.10%
Reduce
35 741.73K $29.41M 1.09%
1.09%
Reduce
36 419.23K $28.86M 1.07%
1.07%
Reduce
37 726.90K $27.75M 1.03%
1.03%
Reduce
38 140.85K $26.92M 1.00%
1.00%
Add
39 701.61K $26.13M 0.97%
0.97%
Add
40 1.14M $25.28M 0.94%
0.94%
Reduce
41 237.31K $25.11M 0.93%
0.93%
Reduce
42 161.01K $24.98M 0.93%
0.93%
Reduce
43 454.97K $24.65M 0.91%
0.91%
Reduce
44 763.28K $24.65M 0.91%
0.91%
Reduce
45 130.16K $24.03M 0.89%
0.89%
Reduce
46 122.88K $23.30M 0.86%
0.86%
Reduce
47 151.66K $23.17M 0.86%
0.86%
Reduce
48 829.21K $22.95M 0.85%
0.85%
Reduce
49 700.13K $22.62M 0.84%
0.84%
Reduce
50 323.32K $21.59M 0.80%
0.80%
Reduce

FAQ

What did Aristotle Capital Boston, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, Aristotle Capital Boston, LLC reported 127 equity positions worth $2.70B in aggregate; its largest disclosed positions were HURN ($72.53M), MTSI ($66.26M), MMSI ($63.72M).

How large is Aristotle Capital Boston, LLC's portfolio?

Aristotle Capital Boston, LLC reported $2.70B of long equity holdings across 127 positions as of 2024-Q4. Top-10 holdings account for 22.0% of reported value.

What is Aristotle Capital Boston, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/aristotle-capital-boston/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →